UK regulator finds Alliance, Advanz carved up market for antibiotic

Alliance Healthcare

25/07/2019 07:33

July 25 (Reuters) - The UK Competition and Markets Authority
(CMA) on Thursday said it had found provisionally that sellers
of antibiotic Nitrofurantoin broke competition law by "arranging
to carve up the market between them".
    The watchdog said from 2014 to at least October 2017, two
suppliers, Advanz Pharma Corp  ADVZ.TO  and Morningside, and a
wholesaler, Alliance Healthcare  ALLA.SI , entered into
arrangements under which Alliance would buy equal volumes of the
drug from each of the suppliers so that they would not compete.

 (Reporting by Justin George Varghese in Bengaluru; editing by
Patrick Graham)
 ((justin.varghese@thomsonreuters.com; Tel: +91 80 6749 3486;
Reuters Messaging:
justin.varghese.thomsonreuters.com@reuters.net))